Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Milestone Pharmaceuticals Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +4 vs. Q3 2024
- Shares held
- 24.6M
- −4.13M (−14.4%) vs. Q3 2024
- Total value
- $57.9M
- +$14.4M (+32.9%) vs. Q3 2024
- New holders
- 10
- 14 more added
- Sold out
- 6
- 14 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,050,686 | $9.56M | 0.00% | −920,658−18.5% | Reduced |
| Millennium Management LLC | 2,703,259 | $6.38M | 0.01% | −75,266−2.7% | Reduced |
| Alta Fundamental Advisers LLC | 2,658,589 | $6.27M | 2.32% | 00.0% | Unchanged |
| RTW Investments, LP | 2,506,102 | $5.91M | 0.09% | −750,000−23.0% | Reduced |
| OrbiMed Advisors LLC | 2,000,000 | $4.72M | 0.10% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,445,264 | $3.41M | 0.24% | −304,736−17.4% | Reduced |
| Bleichroeder LP | 1,326,085 | $3.13M | 0.79% | 00.0% | Unchanged |
| Morgan Stanley | 1,289,141 | $3.04M | 0.00% | +370,829+40.4% | Added |
| BML Capital Management, LLC | 1,136,091 | $2.68M | 1.67% | 00.0% | Unchanged |
| Lion Point Capital, LP | 1,025,806 | $2.42M | 12.68% | −628,348−38.0% | Reduced |
| Goldman Sachs Group Inc | 942,407 | $2.22M | 0.00% | −410,660−30.4% | Reduced |
| Toronto Dominion Bank | 750,000 | $1.77M | 0.00% | +750,000 | New |
| Citadel Advisors LLC | 608,202 | $1.44M | 0.00% | −1,453,320−70.5% | Reduced |
| Stonepine Capital Management, LLC | 500,000 | $1.18M | 0.95% | −499,790−50.0% | Reduced |
| Ikarian Capital, LLC | 466,030 | $1.10M | 0.31% | +110.0% | Added |
| Boxer Capital Management, LLC | 309,007 | $729.3K | 0.06% | +309,007 | New |
| UBS Group AG | 89,506 | $211.2K | 0.00% | +89,506 | New |
| Virtu Financial LLC | 71,955 | $170.0K | 0.01% | +71,955 | New |
| Envestnet Asset Management Inc | 63,742 | $150.4K | 0.00% | −6,848−9.7% | Reduced |
| Northern Trust Corp | 58,108 | $137.1K | 0.00% | +30,772+112.6% | Added |
| Squarepoint Ops LLC | 56,751 | $133.9K | 0.00% | +2,506+4.6% | Added |
| Group One Trading, L.P. | 52,637 | $124.2K | 0.00% | +52,637 | New |
| Dimensional Fund Advisors LP | 39,450 | $92.9K | 0.00% | 00.0% | Unchanged |
| Atria Investments LLC | 38,666 | $91.3K | 0.00% | −1,755−4.3% | Reduced |
| XTX Topco Ltd | 34,054 | $80.4K | 0.01% | +34,054 | New |
| Susquehanna International Group, LLP | 33,092 | $78.1K | 0.00% | +33,092 | New |
| BNP Paribas Arbitrage, SA | 31,133 | $73.5K | 0.00% | +1,924+6.6% | Added |
| Cubist Systematic Strategies, LLC | 30,938 | $73.0K | 0.00% | +30,938 | New |
| Boothbay Fund Management, LLC | 30,790 | $72.7K | 0.00% | +110.0% | Added |
| Cetera Investment Advisers | 24,731 | $58.4K | 0.00% | +60+0.2% | Added |
| Valeo Financial Advisors, LLC | 20,000 | $47.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 19,872 | $46.9K | 0.00% | +2,296+13.1% | Added |
| State Street Corp | 19,117 | $45.1K | 0.00% | −194−1.0% | Reduced |
| National Bank of Canada | 18,700 | $44.1K | 0.00% | +11,600+163.4% | Added |
| Two Sigma Securities, LLC | 16,957 | $40.0K | 0.01% | −6,176−26.7% | Reduced |
| Creative Planning | 14,180 | $33.5K | 0.00% | +1,100+8.4% | Added |
| Beta Wealth Group, Inc. | 14,127 | $33.3K | 0.01% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 13,000 | $30.7K | 0.00% | +2,500+23.8% | Added |
| Jones Financial Companies LLLP | 11,000 | $26.0K | 0.00% | +10,000+1,000.0% | Added |
| Clear Creek Financial Management, LLC | 10,500 | $24.8K | 0.00% | −9,000−46.2% | Reduced |
| Ancora Advisors, LLC | 10,000 | $23.6K | 0.00% | −50,000−83.3% | Reduced |
| Advisor Group Holdings, Inc. | 6,934 | $16.4K | 0.00% | +434+6.7% | Added |
| Simplex Trading, LLC | 4,642 | $10.0K | 0.00% | +4,428+2,069.2% | Added |
| JPMorgan Chase & Co | 900 | $2.12K | 0.00% | +900 | New |
| Citigroup Inc | 329 | $776 | 0.00% | +329 | New |
| Barclays PLC | 100 | $236 | 0.00% | 00.0% | Unchanged |
| Oliver Lagore Vanvalin Investment Group | 100 | $236 | 0.00% | 00.0% | Unchanged |
| Altium Capital Management LP | 0 | $0 | 0.00% | −440,000−100.0% | Sold out |
| Boxer Capital, LLC | 0 | $0 | 0.00% | −309,007−100.0% | Sold out |
| PVG Asset Management Corp | 0 | $0 | 0.00% | −30,345−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −27,931−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −11,074−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −800−100.0% | Sold out |